Low Serum Magnesium Predicts Neurological Events in Patients with Advanced Atherosclerosis

Stroke

Volumn 35, Issue 1, 2004, Pages 22-27

  Amighi, Jasmin ^a   Sabeti, Schila ^a   Schlager, Oliver ^a   Mlekusch, Wolfgang ^a   Exner, Markus ^b   Lalouschek, Wolfgang ^b   Ahmadi, Ramazanali ^a   Minar, Erich ^a   Schillinger, Martin ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Magnesium; Risk factors; Stroke

Indexed keywords

MAGNESIUM;

ADULT; ADVANCED ATHEROSCLEROSIS; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BRAIN ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; FEMALE; HUMAN; HYPOMAGNESEMIA; INTERMITTENT CLAUDICATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; NEUROLOGICAL EVENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STENT; STROKE;

AGED; ARTERIOSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERY DISEASES; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS;

EID: 0346726107     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000105928.95124.1F     Document Type: Article

References (37)

1. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984;108:188-193.
2. Shechter M, Kaplinsky E, Rabinowitz B. The rationale of magnesium supplementation in acute myocardial infarction: a review of the literature. Arch Intern Med. 1992;152:2189-2196.
3. Altura BM, Altura BT. Role of magnesium in patho-physiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest. 1996;224:211-234.
4. Shechter M, Sharir M, Labrador M. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102:2353-2358.
5. Shivakumar K. Model of cardiovascular injury in magnesium deficiency. Med Hypotheses. 2001;56:110-113.
6. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1998;136:480-490.
7. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Association of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC Study. J Clin Epidemiol. 1995; 48:927-940.
8. Paolisso A, Scheen A, d'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33:511-514.
9. Rosolva H, Mayer O, Reaven G. Effects of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab. 1997;82:3783-3785.
10. Singh RB, Rastogi SS, Ghosh S, Niaz MA. Dietary and serum magnesium levels in patients with acute myocardial infarction, coronary artery disease and noncardiac diagnoses. J Am Coll Nutr. 1994;13:139-143.
11. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D, for the Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538-545.
12. Dieter RS, Chu WW, Pacanowski JP, McBride PE, Tanke TE. The significance of lower extremity peripheral arterial disease. Clin Cardiol. 2002;25:3-10.
13. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
14. Szabo C, Farago M, Dora E, Horvath I, Kovach AG. Endothelium-dependent influence of small changes in extracellular magnesium concentration on the tone of feline middle cerebral arteries. Stroke. 1991;22: 785-789.
15. Seelig M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations: magnesium and chloride loss in refractory potassium repletion. Am J Cardiol. 1989; 63:4-21.
16. Dyckner T, Wester PO. The relation between extra and intracellular electrolytes in patients with hypokalemia and/or diuretic treatment. Acta Med Scand. 1987;204:269-282.
17. Shechter M, Merz CN, Rude RK, Paul Labrador MJ, Meisel SR, Shah PK, Kaul S. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Am Heart J. 2000;140:212-218.
18. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol. 1994;102:616-622.
19. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol. 1997;20:426-432.
20. Sherer Y, Bitzur R, Cohen H, Shaish A, Varon D, Schoenfeld Y, Harats D. Mechanism of action of the anti-atherogenic effect of magnesium: lessons from a mouse model. Magnes Res. 2001;14:173-179.
21. Morrill GA, Gupta RK, Kostellow AB, Ma GY, Zhabg A, Altura BT, Altura BM. Mg modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett. 1997;408:191-194.
22. Altura BT, Brust M, Bloom S, Barbour RI, Stempak JG, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA. 1990;87:1840-1844.
23. Maier JA. Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med. 2003;24:137-146.
24. Malpuech-Brugere C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, Lebreton J, Mazur A, Rayssiguier Y. Inflammatory response following acute magnesium deficiency in the rat. Biochem Biophys Acta. 2000; 1501:91-98.
25. Rayssiguier Y, Gueux E, Bussiere L, Durlach J, Mazur A. Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J Am Coll Nutr. 1993;12:133-137.
26. Ouchi Y, Tabata RE, Stergiopoulos K, Sato F, Hattori A, Orimo H. Effects of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 1990;10:732-737.
27. Laurant P, Hayoz D, Brunner H, Berthelot A. Dietary magnesium intake can affect mechanical properties rat carotid artery. Br J Nutr. 2000;84: 757-764.
28. Massey LK. Diary food consumptiom, blood pressure and stroke. J Nutr. 2001;131:1875-1878.
29. Iso H, Stampfer MJ, Manson JE, Rexrode K, Hennekens CH, Colditz GA, Speizer FE, Willett C. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30: 1772-1779.
30. Ascherio A, Rimm EB, Hernan MA, Giovannucci EL, Kawachi I, Stampfer MJ, Willet WC. Intake of potassium, magnesium, calcium and fiber and risk of stroke among US men. Circulation. 1998;98:1198-1204.
31. Yang CY. Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke. 1998;29:411-414.
32. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558.
33. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality: meta-analysis of magnesium in acute myocardial infarction. Circulation. 1992;86:774-779.
34. Ravn HB, Moeldrup U, Brooks CI, Ilkjaer LB, White P, Chew M, Jensen L, Johnson S, Birk-Soerensen L, Hjortdal VE. Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery. Arterioscler Thromb Vasc Biol. 1999;19:569-574.
35. Shechter M, Merz CNB, Stuehlinger GH, Slany J, Pachinger O, Rabinowitz B. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. Am J Cardiol. 2003;91:517-521.
36. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
37. Early administration of intravenous magnesium to high risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet. 2002;360:1189-1196.